116 related articles for article (PubMed ID: 21514825)
1. 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
Chen JJ; Nguyen T; D'Amico DC; Qian W; Human J; Aya T; Biswas K; Fotsch C; Han N; Liu Q; Nishimura N; Peterkin TA; Yang K; Zhu J; Riahi BB; Hungate RW; Andersen NG; Colyer JT; Faul MM; Kamassah A; Wang J; Jona J; Kumar G; Johnson E; Askew BC
Bioorg Med Chem Lett; 2011 Jun; 21(11):3384-9. PubMed ID: 21514825
[TBL] [Abstract][Full Text] [Related]
2. Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency.
Qian W; Chen JJ; Human J; Aya T; Zhu J; Biswas K; Peterkin T; Hungate RW; Arik L; Johnson E; Kumar G; Joseph S; Jona J; Guo HX; Wu Z
Bioorg Med Chem Lett; 2012 Jan; 22(2):1061-7. PubMed ID: 22197141
[TBL] [Abstract][Full Text] [Related]
3. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
[TBL] [Abstract][Full Text] [Related]
4. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
[TBL] [Abstract][Full Text] [Related]
6. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
7. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
[TBL] [Abstract][Full Text] [Related]
8. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
[TBL] [Abstract][Full Text] [Related]
9. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
[TBL] [Abstract][Full Text] [Related]
10. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
[TBL] [Abstract][Full Text] [Related]
11. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
[TBL] [Abstract][Full Text] [Related]
12. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
[TBL] [Abstract][Full Text] [Related]
13. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
16. Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
Chen JJ; Biswas K
Prog Med Chem; 2008; 46():173-204. PubMed ID: 18381126
[No Abstract] [Full Text] [Related]
17. Preparation and optimization of a series of 3-carboxamido-5-phenacylaminopyrazole bradykinin B1 receptor antagonists.
Dressen D; Garofalo AW; Hawkinson J; Hom D; Jagodzinski J; Marugg JL; Neitzel ML; Pleiss MA; Szoke B; Tung JS; Wone DW; Wu J; Zhang H
J Med Chem; 2007 Oct; 50(21):5161-7. PubMed ID: 17880055
[TBL] [Abstract][Full Text] [Related]
18. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
[TBL] [Abstract][Full Text] [Related]
19. Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.
Eles J; Beke G; Vágó I; Bozó E; Huszár J; Tarcsay A; Kolok S; Schmidt E; Vastag M; Hornok K; Farkas S; Domány G; Keserű GM
Bioorg Med Chem Lett; 2012 May; 22(9):3095-9. PubMed ID: 22483585
[TBL] [Abstract][Full Text] [Related]
20. Chromenones as potent bradykinin B1 antagonists.
Bryan MC; Biswas K; Peterkin TA; Rzasa RM; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
Bioorg Med Chem Lett; 2012 Jan; 22(1):619-22. PubMed ID: 22088753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
